Metropolitan Life Insurance Company (MetLife)’s Accolade Inc ACCD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ACCD Stock Details ACCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,524	Closed	-$36.9K	–	2206
2024 Q1	$36.9K	Sell	3,524 -435	-11%	-$4.95K	﹤0.01%	1556
2023 Q4	$47.5K	Hold	3,959	–	–	﹤0.01%	1476
2023 Q3	$41.9K	Buy	3,959 +301	+8%	+$3.95K	﹤0.01%	1506
2023 Q2	$49.3K	Hold	3,658	–	–	﹤0.01%	1423
2023 Q1	$52.6K	Sell	3,658 -268	-7%	-$3.03K	﹤0.01%	1359
2022 Q4	$30.6K	Hold	3,926	–	–	﹤0.01%	1781
2022 Q3	$44.8K	Buy	3,926 +644	+20%	+$7.02K	﹤0.01%	1535
2022 Q2	$24.3K	Hold	3,282	–	–	﹤0.01%	1949
2022 Q1	$57.6K	Sell	3,282 -10,627	-76%	-$196K	﹤0.01%	1521
2021 Q4	$367K	Hold	13,909	–	–	0.01%	1616
2021 Q3	$587K	Hold	13,909	–	–	0.01%	1352
2021 Q2	$755K	Buy	13,909 +4,879	+54%	+$237K	0.01%	1225
2021 Q1	$410K	Buy	9,030 +5,392	+148%	+$260K	0.01%	1536
2020 Q4	$158K	Hold	3,638	–	–	﹤0.01%	2100
2020 Q3	$141K	Buy	+3,638	New	+$125K	﹤0.01%	2009

Other funds holding ACCD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ACCD Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Accolade Inc (ACCD) in Q2 2024, closing a stake of 3,524 shares — an estimated $36.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ACCD in Q3 2020 and held it in 15 quarters. The position peaked at $755K in Q2 2021. 151 funds tracked by Wall St. Rank hold ACCD as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Accolade Inc position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 3,524 Accolade Inc shares in Q2 2024, an estimated $36.9K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Accolade Inc in Q3 2020 and held it in 15 quarters.
Metropolitan Life Insurance Company (MetLife)'s Accolade Inc position peaked at $755K in Q2 2021.
151 funds tracked by Wall St. Rank held Accolade Inc as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.